Idiopathic (Essential) Hypertension Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 68 pages | ID: I0D4D5ADFC2EN
VPAResearch

Abstracts

Idiopathic (Essential) Hypertension ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Idiopathic (Essential) Hypertension disease clinical trials. The research work analyzes the ongoing Idiopathic (Essential) Hypertension clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Idiopathic (Essential) Hypertension treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Idiopathic (Essential) Hypertension clinical trials.

Scope of the Report-

• Ongoing Idiopathic (Essential) Hypertension clinical trials across regions
• Trial information by Phase and Subjects recruited
• Trial information by status, type, sponsor type
• Drugs used for treatment of Idiopathic (Essential) Hypertension
• Both observational and interventional trials analyzed
• Leading companies and universities participating in Idiopathic (Essential) Hypertension clinical trials

Reasons to Buy

• Track competition and design competitive advantages
• Identify right partners to associate with for further research
• Evaluate potential opportunities available in further clinical trials of the disease
• Formulate business development strategies through success rates of clinical trials
• Identify quick markets for recruiting subjects based on trials count by each market

Contents

1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Idiopathic (Essential) Hypertension Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Idiopathic (Essential) Hypertension Trials by Phase
3.2 Ongoing Idiopathic (Essential) Hypertension Trials by Type
3.3 Ongoing Idiopathic (Essential) Hypertension Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Idiopathic (Essential) Hypertension Trials
4.2 Top 10 Countries conducting Idiopathic (Essential) Hypertension Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Idiopathic (Essential) Hypertension Trials by Sponsor Type
5.2 Idiopathic (Essential) Hypertension Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Idiopathic (Essential) Hypertension Trials by year
6.2 Subjects Recruited for Idiopathic (Essential) Hypertension Trials by Phase
6.3 Subjects Recruited for Idiopathic (Essential) Hypertension Trials by Trial Type
6.4 Subjects Recruited for Idiopathic (Essential) Hypertension Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Idiopathic (Essential) Hypertension Trials- Phase
7.2 Ongoing Idiopathic (Essential) Hypertension Trials- Phase
7.3 Ongoing Idiopathic (Essential) Hypertension Trials- Phase
7.4 Ongoing Idiopathic (Essential) Hypertension Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

List Of Figures

LIST OF FIGURES

Figure 1: Idiopathic (Essential) Hypertension- Clinical Trials by Country
Figure 2: Idiopathic (Essential) Hypertension- Clinical Trials by Phase of Development, 2018
Figure 3: Idiopathic (Essential) Hypertension- Clinical Trials by Status, 2018
Figure 4: Idiopathic (Essential) Hypertension- Clinical Trials by Type, 2018
Figure 5: Idiopathic (Essential) Hypertension- Clinical Trials Split by Region, 2000-2018
Figure 6: Idiopathic (Essential) Hypertension- Clinical Trials by Type of Economy, 2018
Figure 7: Idiopathic (Essential) Hypertension- Enrolment by Phase, 2018
Figure 8: Idiopathic (Essential) Hypertension- Enrolment by Trial Type, 2018
Figure 9: Idiopathic (Essential) Hypertension- Enrolment by Recruitment Status, 2018
Figure 10: Idiopathic (Essential) Hypertension- Clinical Trials by Sponsor Type, 2018
Figure 11: Idiopathic (Essential) Hypertension- Enrolment by Type of Sponsors
Figure 12: Idiopathic (Essential) Hypertension- Enrolment by Leading Sponsors

List Of Tables

LIST OF TABLES

Table 1: Idiopathic (Essential) Hypertension- Clinical Trials by Sponsor Type, 2018
Table 2: Idiopathic (Essential) Hypertension- Clinical Trials by Economy Type, 2018
Table 3: Idiopathic (Essential) Hypertension- Clinical Trials by Region, 2018
Table 4: Idiopathic (Essential) Hypertension- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Idiopathic (Essential) Hypertension- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Idiopathic (Essential) Hypertension- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Idiopathic (Essential) Hypertension- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Idiopathic (Essential) Hypertension- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Idiopathic (Essential) Hypertension- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company